Vogelsang, Tilman L. R.
Schmoeckel, Elisa
Kuhn, Christina
Blankenstein, Thomas
Temelkov, Mina
Heidegger, Helene
Kolben, Theresa Maria
Kolben, Thomas
Mahner, Sven
Mayr, Doris
Jeschke, Udo
Vattai, Aurelia
Article History
Received: 10 February 2020
Accepted: 3 March 2020
First Online: 10 March 2020
Compliance with ethical standards
:
: T.M.K. is employed at and is holding stocks in Roche AG. T.K.’s relative works for Roche AG and he is holding stocks in Roche AG. S.M. receives grants from Roche AG, PharmaMar, Tesaro, MEDAC and AstraZeneca and reimbursements and honoraria from Roche AG, PharmaMar, Clovis, Tesaro, AbbVie, SensorKinesis, MEDAC, AstraZeneca, Novartis and MSD. S.M. receives research support, honoraria, travel expenses and advisory board from AstraZeneca, Clovis, AddVie, MEDAC, MSD, Novartis, PharmaMar, Roche AG, SensorKinesis, Tesaro, GSK and Teva. All other authors declare that they have no conflicts of interest.
: All patients gave informed consent prior to study participation. All procedures were performed according to the ethical standards of the institutional and/or national research committee and with the declaration of Helsinki of 1964 and its later amendments. This study was approved by the local ethics committee of Ludwig-Maximilians-University Munich, Germany (167–14).
: Informed consent was obtained from all individual participants included in this study.